TABLE 2:

Clinical features of 11 patients with ICA occlusion

Patient/Age(y)/SexInitial Occlusion Site*Urokinase Dose (U)Time from Onset (min)Occlusion Site after ProcedureNIHSS ScoremRS Score at 3 mo
AdmissionStart of AngiographyEnd of ProcedureInitial24 h3 mo
13/69/MR C3/prox M1600,00060120240C M3201373
14/73/FR C1/prox M1420,000180210270P M316200
15/76/ML C2/prox M1420,0004070150Angular M42521112
16/69/FR C4/prox M1600,000120150240C4191173
17/82/FL C3/mid M1600,00060110210Angular M42825245
18/66/MR C1/mid M1480,00060100170No21800
19/58/ML C1/mid M1420,0005080150No261352
20/78/FL C4/prox M1480,000190240300M22618143
21/83/ML C3/distal M1420,00040100180Angular M4 A42823235
22/69/MR C2/mid M1480,00070120220C M41713114
23/61/M§L C2/distal M1600,00050110300FCM2 A42928DeadDead
  • Note.—A4 indicates the supracallosal segment of the anterior cerebral artery; C1, knee portion of the ICA; C2, cisternal portion of the ICA; C3, anterior knee of the ICA; C4, cavernous portion of the ICA; dist M1, distal third of the M1; prox M1, proximal third of the M1; mid M1, middle third of the M1.

  • * Proximal end/distal end of clot.

  • Perforation.

  • L leg embolism.

  • § Massive cerebral infarct.